Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
Press Releases
Averna Therapeutics  
January 27, 2025

Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer

Dr. Barnes brings more than 25 years of biotech leadership expertise and a proven track record in advancing transformative early-stage therapies

avatar profile Olean Times Herald

Olean Times Herald


Local & Social